Merck KGaA’s arpraziquantel validated by European Medicines Agency
Positive scientific opinion by EMA would create pathway for arpraziquantel in African endemic countries
Read More
Tag: Merck KGaA
Immutep in clinical trail collaboration with Merck KGaA and Pfizer
Research will focus on eftilagimod alpha and avelumab for the treatment of urothelial cancer
Read More
Merck KGaA and BioMed X launch new joint cancer research programme
New partnership will explore the role of extrachromosomal DNA in cancer
Read More
Merck KGaA, IAVI and Serum Institute link up to develop COVID-19 mAbs
Agreement will see partners develop SARS-CoV-2 neutralising monoclonal antibodies
Read More
Merck KGaA out-licenses osteoarthritis programme to Novartis
Potential disease modifying osteoarthritis candidate is phase II ready
Read More
FDA approval for Bavencio combo in advanced RCC
The decision was based on positive results from the Phase III JAVELIN Renal 101 study.
Read More
GSK retains leading position on access to medicines list
GlaxoSmithKline has retained its top position among a global list of pharmaceutical companies striving to make their medicines, vaccines and diagnostics more accessible for people in low- and middle-income countries.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
